The new WHO guidance strengthens the fight against Plasmodium vivax malaria by combining safer radical cure medicines with routine G6PD testing to prevent dangerous side effects. By clearing both ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. GENEVA (AP) — Switzerland’s medical products ...

Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant laboratory experiments, scientists have uncovered how a pair of these ...

Malaria kills over 600,000 people a year, and as the climate warms, the potential range of the disease is growing. While some drugs can effectively prevent and treat malaria, resistance to those drugs ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the company's French headquarters in Rueil-Malmaison ZURICH ...

A recent study published in The New England Journal of Medicine has revealed that mass administration of ivermectin, a drug long used for treating river blindness and scabies, can significantly reduce ...

Malaria is a mosquito-borne parasitic disease that can cause serious illness and death. It is caused by a parasite called Plasmodium and is transmitted through the bite of infected female Anopheles ...

A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. UCSF chemists remodeled their structures to make them more soluble, while maintaining their ...